COPPERWYND FINANCIAL, LLC – Regeneron Pharmaceuticals, Inc. Transaction History
COPPERWYND FINANCIAL, LLC portfolio value:
$568,000
portfolio value
COPPERWYND FINANCIAL, LLC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -4.41% | -38 shares | 58K | $688.87 | 824 |
Q2 2022 | share | Decrease | -1.37% | -12 shares | -100K | $591.13 | 862 |
Q1 2022 | share | Increase | +23.80% | 168 shares | 164K | $698.42 | 874 |
Q4 2021 | share | Increase | +0.28% | 2 shares | 20K | $642.51 | 706 |
Q3 2021 | share | Increase | 0.00% | 704 shares | 426K | $605.18 | 704 |
Q2 2021 | share | Decrease | -100.00% | -920 shares | -435K | $558.54 | 0 |
Q1 2021 | share | Increase | +47.91% | 298 shares | 135K | $473.14 | 920 |
Q4 2020 | share | Increase | +31.50% | 149 shares | 35K | $483.11 | 622 |
Q3 2020 | share | Increase | +30.30% | 110 shares | 39K | $559.78 | 473 |
Q2 2020 | share | Increase | 0.00% | 363 shares | 226K | $623.65 | 363 |